US Patent 7495102 Azaindole inhibitors of aurora kinases
Patent 7495102 was granted and assigned to Smithkline Beecham Limited on February, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+86 characters)
Article
Patent abstract
The present invention relates to a compound represented by Formula (I):
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07495102 Azaindole inhibitors of aurora kinases US Patent 7495102 Azaindole inhibitors of aurora kinases
Infobox
Patent Number
0749510200
Patent Number
749510200
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074951020
Date of Patent
February 24, 2009
0Patent Application Number
118551830
Date Filed
September 14, 2007
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074951020
Date of Patent
February 24, 2009
0Patent Application Number
118551830
Date Filed
September 14, 2007
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07495102 Azaindole inhibitors of aurora kinases
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07495102
Date of patent
February 24, 2009
Patent application number
11855183
Date Filed
September 14, 2007
Patent primary examiner
Find more entities like US Patent 7495102 Azaindole inhibitors of aurora kinases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
